Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Launches Next Generation Sequencing Services

Published: Tuesday, January 21, 2014
Last Updated: Tuesday, January 21, 2014
Bookmark and Share
Services provide a complete sample-to-answer solution including biological interpretation of customer’s results.

Results are delivered within 4-6 weeks of sample submission. All customers receive results and data analyses in the form of a highly advanced interactive report. The interactive report summarizes results in simple tables and diagrams and provides easy access to identify interesting microRNAs and genes through use of Exiqon’s proprietary miRSearch bioinformatics search tool which saves time and effort compared to traditional literature and database searches by rapidly presenting relevant information.


“This product offering is based on years of collaboration with our customers and numerous man-years of product development. Valuable customer input has defined the importance of combining high quality, fast turnaround time and thorough in depth reporting that can be readily understood by customers without prior training in Next Generation Sequencing” said Senior Vice President Sales & Marketing, Dr. Henrik M. Pfundheller.


The new offer for Next Generation Sequencing services complements Exiqon’s existing portfolio of services for qPCR and microarray profiling and allows Exiqon to leverage 9 years of experience in servicing customers with high quality data through modern service laboratories. 


Exiqon’s Next Generation Sequencing services integrate technical support in the planning phase with advanced sample preparation, library preparation, sequence generation based on state-of-the-art equipment and proprietary data analysis. These services address the need in basic research to reveal known as well as unknown microRNAs and other RNAs. Exiqon also offers a full range of LNA™-enhanced qPCR products for validation of targets identified by Next Generation Sequencing and LNA™ products for any down-stream functional analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Gene Behind Rare Childhood Syndrome Identified
Online activism by one patient’s mother spurred research collaboration which led to the identification of a new genetic syndrome.
Resilience Project Identifies Rare Unaffected Individuals
Researchers from Mount Sinai and Sage Bionetworks report analysis of nearly 600,000 genomes for resilience project.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Children With Cancer To Get New Gene Test
Pilot study will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment.
How The Bat Got Its Wings
Finding may provide clues to human limb development and malformations.
Lupus Study Shows Precision Medicine’s Potential to Define the Genetics of Autoimmune Disease
Researchers at UT Southwestern have used next-generation DNA sequencing technology to identify more than 1,000 gene variants that affect susceptibility to SLE.
Illuminating the Broad Spectrum of Disease
PRISM efficiently tests drug compounds in multiple cell lines simultaneously, accelerating discovery of targeted therapies in the service of precision medicine.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!